(Q44691945)

5 December 2017

title

Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer (English)

1 reference

5 December 2017

Jian-Guo Ma

1 reference

5 December 2017

Zheng-Kai He

1 reference

5 December 2017

Jian-Hua Ma

1 reference

5 December 2017

Wen-Ping Li

1 reference

5 December 2017

Guang Sun

1 reference

5 December 2017

publication date

23 January 2013

1 reference

Journal of International Medical Research

5 December 2017

published in

1 reference

5 December 2017

1 reference

5 December 2017

1 reference

5 December 2017

page(s)

38-47

1 reference

The present and future burden of urinary bladder cancer in the world

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Bladder cancer in 2010: how far have we come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Role of PCDH10 and its hypermethylation in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

PCDH10 is a candidate tumour suppressor gene in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Epigenetic inactivation of PCDH10 in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Identification and characterization of human PCDH10 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Guidelines on bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Declaration of Helsinki, 2008: implications for stakeholders in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Bladder wash cytology at diagnosis of Ta-T1 bladder cancer is predictive for recurrence and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Strategies to prevent progression of high-risk bladder cancer at initial diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

Predictive factors for recurrence progression and cancer specific survival in high-risk bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476989

21 January 2018

Identifiers

DOI

10.1177/0300060513476989

1 reference

5 December 2017

1 reference